跳至主要内容
临床试验/NCT04946838
NCT04946838已完成不适用

Transcutaneous Electrical Nerve Stimulation for Labor Pain Control in Combination With Cardiotocography

Aalborg University2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2021年7月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
2
主要终点
Visual Analog scale (VAS)

研究概览

简要总结

Transcutaneous electrical nerve stimulation (TENS) is a non-invasive electro-physical modality used for several pain conditions including labor pain control. Despite several years of research, there is still no agreement within the literature regarding the selection of TENS parameters. It is aimed to investigate TENS1 alternating between 4 to 100 Hz compared to sham-TENS.

The present study aims to evaluate TENS in combination with cardiotocography (CTG).

The combination of TENS with CTG in a feedback-loop has not been reported in any studies before.

详细描述

Midwives and the study investigator will ask parturients, who are admitted to the labor ward at Region Hospital Herning satisfying the inclusion and exclusion criteria, whether they are interested in attending the experimental session.

The study will be conducted as soon as the subject is admitted at the labor ward. The study will only be conducted during early and active labor and not during the birth of the baby.

The subject in this study includes the package of a parturient and her neonate (after birth) as we also obtain data about the neonate. Hereby, two consent forms will be obtained. As this study is a non-invasive study, it is decided to have at least the consent of one parent.

The investigator will fill out a screening questionnaire about the laboring parturient in cooperation with the subject and the midwife, including screening questions related to inclusion and exclusion criteria before the experimental session starts.

The study will last approximately one hour and will be conducted during laboring circumstances. KT (Kenoja Thuvarakan) will carry out the experiment, and she will be present in the delivery room during the whole session.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Double-blinded

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Singleton pregnancy
  • Vertex presentation
  • Speak, read and understand Danish

排除标准

  • Gestational age < 37+0 weeks
  • Gestational age > to 41+6 weeks
  • High-risk pregnancies (including risk factors: eclampsia, pre-eclampsia, diabetes, gestational diabetes, hypertension (above 140/90), and hypotension (below 90/60), Intrauterine growth restriction (IUGR), polyhydramnious, and oligohydramnious).
  • Pre-gestational body mass index (BMI) above 40 kg/m2
  • Use of fetal scalp-electrode during the experiment
  • Use of pacemakers and other electronic implants
  • Severe arrhythmia
  • Present musculoskeletal illnesses (including myopathy and arthritis).
  • Chronic pain within last 6 months (Pelvic girdle pain (PGP) to a mild degree (VAS 0-6 cm) is accepted in the experiment. Severe degree (VAS 6-10 cm) (e.g. bedridden or difficulty walking) especially within 24 hours before birth is excluded).
  • Present/previous neurologic illnesses (including epilepsy, migraine, and sclerosis).
  • Present medicated mental disorders (including dementia, personality disorders, bipolar, ADHD, and anxiety).
  • Dermatological disorders (including skin allergy, tattoos or scars on the locations of electrodes)
  • Use of other long-acting pain relief before the experiment (including Epidural, Morphine less than 16 hours before experiment), Acupuncture, Paracetamol (less than 8 hours before experiment), Cocktail (less than 8 hours before experiment), nitrous oxide (less than one hour before experiment), sterile water injection (less than two hours before experiment).
  • Use of TENS 48 hours before the trial
  • Drug addiction defined as the use of cannabis, opioids or other drugs.
  • Lack of ability to cooperate

结局指标

主要结局

Visual Analog scale (VAS)

时间窗: Baseline, 10 minutes post stimulation, 30 minutes post stimulation

10-cm pain intensity scale with 0 cm is no pain and 10 cm is unbearable pain. Decreased cm after baseline measurement indicates pain relief.

Pain pressure threshold (PPT)

时间窗: Baseline, 10 minutes post stimulation, 30 minutes post stimulation

Pain sensitivity measurement also defined as the minimum pressure needed to evoke a pain response measured in kPa. Increased kPa after baseline measurement indicates pain relief.

次要结局

  • Recommend TENS to others(Right after last measurements of VAS & PPT)
  • Satisfaction of TENS(Right after last measurements of VAS & PPT)
  • Interest in the use of TENS again(Right after last measurements of VAS & PPT)
  • Experienced pain reduction(Right after last measurements of VAS & PPT)

研究者

发起方
Aalborg University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Kenoja Thuvarakan

Principle Investigator

Aalborg University

研究点 (2)

Loading locations...

相似试验